BitMex co-founder Arthur Hayes is still making one of his most aggressive predictions, placing Hyperliquid’s hype token in the path to potentially reach $5,000.
In a podcast interview with Kyle Chasse, he projected into an explosive expansion in the Stablecoin market. He argued that total supply could rise above $10 trillion, causing a surge in speculative trading.
How hype prices can reach $5,000
According to Hayes, such terms encourage retail investors to chase oversized returns through leverage, increasing demand for platforms that cater to risky transactions.
Sponsored Sponsors
“I don’t have enough money to do what I want to do. But there’s this leveraged trading venue. In this leveraged trading location, choose the correct meme stock of coins or Americans and choose the correct meme stock on the casino stock market.
In his view, this risk-on environment exerts fuel demand for platforms like high lipids when capital flows into high-yield assets. As a result, this will benefit Hyperliquid hype tokens as market liquidity grows and platform adoption surges.
“This is a system that the staff chose to create and the population is moving along. I’m going to own a casino where plebs gamble,” Hayes said.
Hayes’ remarks are built on previous comments in Tokyo, and he suggested that the hype could earn 126 times more profits in three years.
High lipids solidify themselves as one of the most influential and decentralized exchanges in the code, so their predictions resonate more strongly than they are now.
Unlike its competitors, the platform operates perfectly on its own blockchain, focusing on permanent futures contracts. This allows traders to guess without expiration date.
That design choice led to incredible traction. High lipids currently account for more than 60% of the permanent futures market. That trading volume already outweighs Robinhood, and it lacks Binance’s advantage.
Furthermore, the platform’s financial performance is equally impressive. Research firm ASXN reported that high lipids generated a net profit of $1.2 billion in 2024, snatching Nasdaq’s $1.13 billion.
This comparison highlights the scale of its growth, especially given that high lipids operate in a workforce of 800 times more.
Importantly, in the case of token holders, 98% of the exchange’s revenue is directed towards buying back hype. This constant purchasing pressure has underpinned token performance, surpassing $57, a recent high.
